A new era of precision medicine is taking shape with remarkable speed, and few recent developments exemplify this better than the success of CRISPR-based and gene therapy interventions for rare neurogenetic diseases. In the past several weeks, a series of global...

We’re proud to share that InGeNA CEO Dr Erin Evans has been appointed as one of seven individual members of the newly formed Genomics Australia Advisory Council, chaired by the Genomics Commissioner Tiffany BoughtwoodWe are especially delighted to see industry and...

The Industry Genomics Network Alliance (InGeNA) has made a submission to the Treasury Laws Amendment (Genetic Discrimination) Bill 2025 consultation, representing the collective voice of Australia’s genomics and precision medicine industry.  We strongly support the...